In other news, EVP Paul A. Mahon sold 6,000 shares of United Therapeutics stock in a transaction that occurred on Thursday, February 2nd.

Source: https://www.etfdailynews.com/2023/02/27/canada-pension-plan-investment-board-boosts-position-in-united-therapeutics-co-nasdaquthr/

Morgan Stanley increased its stake in shares of United Therapeutics by 51.9% in the fourth quarter.

Source: https://www.etfdailynews.com/2023/07/15/asset-management-one-co-ltd-invests-4-24-million-in-united-therapeutics-co-nasdaquthr/

United Therapeutics Co. has a one year low of $204.44 and a one year high of $283.09.

Source: https://www.dailypolitical.com/2023/11/18/canada-pension-plan-investment-board-boosts-position-in-united-therapeutics-co-nasdaquthr.html

United Therapeutics had a return on equity of 15.49% and a net margin of 36.76%.

Source: https://www.etfdailynews.com/2023/05/21/belpointe-asset-management-llc-makes-new-investment-in-united-therapeutics-co-nasdaquthr/